scispace - formally typeset
F

Felicia Antohe

Researcher at Romanian Academy

Publications -  60
Citations -  1765

Felicia Antohe is an academic researcher from Romanian Academy. The author has contributed to research in topics: Endothelial stem cell & Internal medicine. The author has an hindex of 18, co-authored 53 publications receiving 1603 citations.

Papers
More filters
Journal ArticleDOI

The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans

TL;DR: Ex vivo placental analyses of the maternofetal transfer of a recombinant, humanized IgG1 antibody in which His435 has been mutated to alanine demonstrate that binding of an IgG to FcRn is a prerequisite for transport across the perfused placenta.
Journal ArticleDOI

Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice.

TL;DR: The data demonstrate that FcRn is expressed in functionally active form in endothelial cells, indicating that these cells are a possible site at which serum IgG homeostasis is maintained.
Journal ArticleDOI

Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey.

TL;DR: The cell biological findings that revealed that endothelial cell have the attributes to fulfill the transport function are discussed, mainly the results obtained indicate that transcytosis of albumin, low‐density lipoproteins, metaloproteases, and insulin, is performed by cargo‐vesicles and their generated channels.
Journal ArticleDOI

Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells.

TL;DR: The results showed that FcRn is expressed by human placental endothelial cells, in a functionally active form, and transcytosis of IgG in HPEC is a time-dependent process that takes place preferentially from the basolateral to the apical compartment, chloroquine sensitive.
Journal ArticleDOI

Effect of enoxaparin on high glucose-induced activation of endothelial cells.

TL;DR: It is suggested that enoxaparin reduces the high glucose-induced activation of endothelial cells by inhibiting monocyte adhesion through a mechanism that involves cell adhesion molecules and NF-kappaB.